MLAB (STOCKS)
Mesa Laboratories Inc
$105.480000
-1.870000 (-1.74%)
Prev close: $107.350000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Medical Specialties
- CEO
- Siddhartha C. Kadia
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $581.89M
- Employees
- 730
- P/E (TTM)
- 87.46
- P/B (TTM)
- 3.13
- Dividend Yield
- 60.68%
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
3
Strong Buy
3
Buy
3
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Mar 2026 (Q4)
|
$-0.75 | $0.35 | -1.0968 | -316.26% |
|
Dec 2025 (Q3)
|
$0.65 | $0.28 | +0.3678 | +130.33% |
|
Sep 2025 (Q2)
|
$0.45 | $0.16 | +0.2868 | +175.74% |
|
Jun 2025 (Q1)
|
$0.85 | $0.45 | +0.4046 | +90.84% |
Financial Statements
| Revenues | $249.13M |
| Benefits Costs and Expenses | $237.12M |
| Cost Of Revenue | $90.86M |
| Costs And Expenses | $237.12M |
| Gross Profit | $158.27M |
| Nonoperating Income/Loss | -$6.50M |
| Operating Expenses | $139.76M |
| Research and Development | $20.31M |
| Other Operating Expenses | $119.45M |
| Operating Income/Loss | $18.51M |
| Income/Loss From Continuing Operations After Tax | $12.01M |
| Income/Loss From Continuing Operations Before Tax | $12.01M |
| Income Tax Expense/Benefit | $5.30M |
| Income Tax Expense/Benefit, Current | $6.58M |
| Income Tax Expense/Benefit, Deferred | -$1.28M |
| Net Income/Loss | $6.71M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | $6.71M |
| Net Income/Loss Available To Common Stockholders, Basic | $6.71M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | $1.22 |
| Diluted Earnings Per Share | $1.21 |
| Basic Average Shares | 5,514,000 |
| Diluted Average Shares | 5,565,000 |
| Common Stock Dividends | $0.64 |
| Assets | $427.75M |
| Current Assets | $106.27M |
| Inventory | $26.37M |
| Other Current Assets | $79.90M |
| Noncurrent Assets | $321.48M |
| Fixed Assets | $30.61M |
| Other Non-current Assets | $290.87M |
| Liabilities | $241.50M |
| Current Liabilities | $61.90M |
| Accounts Payable | $4.93M |
| Wages | $19.01M |
| Other Current Liabilities | $37.96M |
| Noncurrent Liabilities | $179.60M |
| Long-term Debt | $67.50M |
| Other Non-current Liabilities | $112.10M |
| Equity | $186.25M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $186.25M |
| Liabilities And Equity | $427.75M |
| Net Cash Flow From Operating Activities | $42.83M |
| Net Cash Flow From Operating Activities, Continuing | $42.83M |
| Net Cash Flow From Investing Activities | -$3.25M |
| Net Cash Flow From Investing Activities, Continuing | -$3.25M |
| Net Cash Flow From Financing Activities | -$41.85M |
| Net Cash Flow From Financing Activities, Continuing | -$41.85M |
| Net Cash Flow | -$2.27M |
| Net Cash Flow, Continuing | -$2.27M |
| Comprehensive Income/Loss | $13.13M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | $13.13M |
| Other Comprehensive Income/Loss | $13.13M |